Get started
Medeon Biodesign, Inc.Medeon Biodesign, Inc.Medeon Biodesign, Inc.

Medeon Biodesign, Inc.

No trades
See on Supercharts
OverviewFinancialsDiscussionsTechnicalsForecastSeasonals

6499 chart


Full chart

6499 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪8.31 B‬ TWD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−8.1 TWD
Net income (FY)
‪−805.51 M‬ TWD
Revenue (FY)
‪292.81 M‬ TWD
Shares float
‪33.19 M‬
Beta (1Y)
0.32

About Medeon Biodesign, Inc.


Sector
Electronic Technology
Industry
Electronic Equipment/Instruments
CEO
Yu Te Chang
Website
medeonbio.com
Headquarters
Taipei
Founded
2012
ISIN
TW0006499007
FIGI
BBG007NPQT83
Medeon Biodesign, Inc. engages in the development, manufacture, and sale of medical equipment. It specializes in minimally invasive surgery products. The company’s products include minimally invasive laparoscopic surgery and minimally invasive cardiac catheterization surgery related medical equipment. Medeon Biodesign was founded on December 22, 2012 and is headquartered in Taipei, Taiwan.

Check out other big names from the same industry as 6499.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6499 is 91.6 TWD — it has increased by 1.33% in the past 24 hours. Watch Medeon Biodesign, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange Medeon Biodesign, Inc. stocks are traded under the ticker 6499.
6499 stock has fallen by −0.22% compared to the previous week, the month change is a −2.76% fall, over the last year Medeon Biodesign, Inc. has showed a 98.48% increase.
We've gathered analysts' opinions on Medeon Biodesign, Inc. future price: according to them, 6499 price has a max estimate of 210.00 TWD and a min estimate of 210.00 TWD. Watch 6499 chart and read a more detailed Medeon Biodesign, Inc. stock forecast: see what analysts think of Medeon Biodesign, Inc. and suggest that you do with its stocks.
6499 reached its all-time high on Dec 18, 2015 with the price of 192.7 TWD, and its all-time low was 3.3 TWD and was reached on Dec 11, 2014. View more price dynamics on 6499 chart.
See other stocks reaching their highest and lowest prices.
6499 stock is 2.32% volatile and has beta coefficient of 0.32. Track Medeon Biodesign, Inc. stock price on the chart and check out the list of the most volatile stocks — is Medeon Biodesign, Inc. there?
Today Medeon Biodesign, Inc. has the market capitalization of ‪8.34 B‬, it has decreased by −1.53% over the last week.
Yes, you can track Medeon Biodesign, Inc. financials in yearly and quarterly reports right on TradingView.
Medeon Biodesign, Inc. is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
6499 earnings for the last quarter are −1.87 TWD per share, whereas the estimation was −1.70 TWD resulting in a −10.32% surprise. The estimated earnings for the next quarter are −1.93 TWD per share. See more details about Medeon Biodesign, Inc. earnings.
Medeon Biodesign, Inc. revenue for the last quarter amounts to ‪108.00 M‬ TWD, despite the estimated figure of ‪121.00 M‬ TWD. In the next quarter, revenue is expected to reach ‪111.00 M‬ TWD.
6499 net income for the last quarter is ‪−178.16 M‬ TWD, while the quarter before that showed ‪−177.99 M‬ TWD of net income which accounts for −0.09% change. Track more Medeon Biodesign, Inc. financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Medeon Biodesign, Inc. EBITDA is ‪−701.39 M‬ TWD, and current EBITDA margin is −268.76%. See more stats in Medeon Biodesign, Inc. financial statements.
Like other stocks, 6499 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Medeon Biodesign, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Medeon Biodesign, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Medeon Biodesign, Inc. stock shows the buy signal. See more of Medeon Biodesign, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.